首页> 外文期刊>Vaccine >Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia
【24h】

Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia

机译:口服接种耶尔森氏菌假结核的III型分泌突变体可保护免受强毒耶尔森氏菌的口服,腹膜内或鼻内攻击

获取原文
获取原文并翻译 | 示例
           

摘要

The enteric pathogen Yersinia pseudotuberculosis (Yptb) causes gastroenteritis, mesenteric lymphadenitis, and systemic infections in humans, livestock, and wild animals. Yptb Type III secretion system (pTTSS) mutants efficiently colonize lymphoid tissues, but not the gastrointestinal tract, spleen, or liver. Here, we show that a single oral inoculation of pTTSS mutants prevents morbidity in almost 100% of mice challenged intragastrically with virulent Yptb. In addition, a single oral inoculation of a pTTSS mutant protected 50% of mice challenged intraperitoneally or intranasally with virulent Yptb. In addition, the intranasally challenged mice that succumbed to infection lived significantly longer than non-immunized mice. Thus, pTTSS mutants can function as live attenuated vaccine when delivered orally. Potential uses for these attenuated strains include use as a livestock vaccine, a rodent plague control reagent in endemic areas around the world, and a vector for delivery of other antigens to the mesenteric lymph nodes.
机译:肠道病原体假结核耶尔森氏菌(Yptb)引起胃肠炎,肠系膜淋巴结炎和人类,牲畜和野生动物的全身感染。 Yptb III型分泌系统(pTTSS)突变体有效地定居淋巴组织,但不能定居胃肠道,脾脏或肝脏。在这里,我们表明单次口服接种pTTSS突变体可在几乎100%的小鼠用强毒Yptb进行胃内攻击时预防发病。另外,pTTSS突变体的单次口服接种保护了50%的腹膜内或鼻内用强毒Yptb攻击的小鼠。另外,屈服于感染的经鼻内攻击的小鼠比未免疫的小鼠活得多。因此,当口服递送时,pTTSS突变体可以充当减毒活疫苗。这些减毒株的潜在用途包括用作家畜疫苗,在世界各地的流行地区使用鼠疫鼠疫控制试剂以及将其他抗原递送至肠系膜淋巴结的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号